bluebird bio Newsroom

Bluebird Bio (BLUE) Gets a Buy From Bank of America Securities

TipRanksJul 10 09:18 ET

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Bluebird Bio (BLUE) and Nuvalent (NUVL)

TipRanksMay 14 06:45 ET

Bluebird Bio (BLUE) Receives a Hold From RBC Capital

TipRanksMay 10 07:01 ET

Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Bluebird Bio (BLUE) and Viatris (VTRS)

TipRanksMay 10 06:06 ET

William Blair Sticks to Its Hold Rating for Bluebird Bio (BLUE)

TipRanksMay 9 14:40 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE), Sarepta Therapeutics (SRPT) and Jazz Pharmaceuticals (JAZZ)

TipRanksApr 8 22:06 ET

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS) and Bluebird Bio (BLUE)

TipRanksMar 29 04:25 ET

Bluebird Bio Analyst Ratings

BenzingaMar 27 08:37 ET

Bluebird Bio (BLUE) Receives a Hold From RBC Capital

TipRanksMar 27 06:41 ET

Buy Rating Upheld for Bluebird Bio Amidst Revenue Miss and Promising Gene Therapy Launch

TipRanksMar 27 05:15 ET

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)

TipRanksMar 26 20:05 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Bluebird Bio (BLUE) and BeiGene (BGNE)

TipRanksMar 26 19:55 ET

Hold Rating on Bluebird Bio Amidst Gradual Patient Starts and Funding Steps

TipRanksMar 26 17:30 ET

Wedbush Adjusts Bluebird Bio Price Target to $1.72 From $1.68, Maintains Neutral Rating

MT NewswiresMar 26 12:10 ET

Optimistic Outlook for Bluebird Bio: Buy Rating Affirmed on Extended Financial Runway and Profitability Prospects

TipRanksMar 21 02:40 ET

Bluebird Bio Analyst Ratings

BenzingaMar 19 09:11 ET

Wedbush Maintains Neutral on Bluebird Bio, Lowers Price Target to $1.68

BenzingaMar 19 09:11 ET

Wedbush Adjusts Bluebird Bio's Price Target to $1.68 From $3, Maintains Neutral Rating

MT NewswiresMar 19 07:24 ET

Bluebird Bio Analyst Ratings

BenzingaMar 5 06:23 ET

Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), Sarepta Therapeutics (SRPT) and Alcon (ALC)

TipRanksFeb 1 00:40 ET